ImmuCell (ICCC) had the highest return between March 1, 1991 and March 31, 1991 by a US stock in the Biotechnology Industry, returning 142.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
ImmuCell (ICCC) | 3/1/1991 - 3/31/1991 | 142.44% |
Celldex Therapeutics (CLDX) | 3/1/1991 - 3/31/1991 | 55.26% |
Amgen (AMGN) | 3/1/1991 - 3/31/1991 | 45.44% |
Compass Therapeutics (CMPX) | 3/1/1991 - 3/31/1991 | 26.67% |
Insmed (INSM) | 3/1/1991 - 3/31/1991 | 21.43% |
Anixa Biosciences (ANIX) | 3/1/1991 - 3/31/1991 | 20.9% |
Heron Therapeuti (HRTX) | 3/1/1991 - 3/31/1991 | 19.23% |
CEL-SCI (CVM) | 3/1/1991 - 3/31/1991 | 11.11% |
GT Biopharma (GTBP) | 3/1/1991 - 3/31/1991 | 0% |
Lisata Therapeutics (LSTA) | 3/1/1991 - 3/31/1991 | 0% |
Vera Therapeutics (VERA) | 3/1/1991 - 3/31/1991 | -4.88% |
Abeona Therapeutics (ABEO) | 3/1/1991 - 3/31/1991 | -22.22% |